NEW YORK - Wall Street gained ground on Monday and surging technology shares pushed the Nasdaq to a record closing high, as promising trial results from potential Covid-19 vaccines helped investors look beyond spiraling new cases of the disease.
Most recently, drugs from AstraZenica, CanSino Biologics Inc and from a partnership between Pfizer Inc and German biotech firm BioNTech were safely administered and induced immune responses. The US Congress, still looking to mitigate the pandemic's economic effects, was set for a week of partisan wrangling over a new relief package, with two weeks until enhanced jobless benefits expire for millions of Americans.
In aggregate, analysts now expect S&P 500 second-quarter earnings to have dropped 43.2% year-on-year, per Refinitiv. Moderna Inc shares tumbled 12.8% on positive results from its competitors' rival Covid-19 drug trials. Electric automaker Tesla Inc rose 9.5% to reach a record closing high of $1,643.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
1 killed, 8 injured after three men open fire on busy street in Washington DCWASHINGTON, DC: At least one person died and eight others were injured after three men opened fire on a busy street in Washington DC on Sunday ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Thousands of Thai protesters take to street, calling for government to resignThousands of mainly young and black-clad Thai protesters converged on Saturday at Bangkok's Democracy Monument as the city's largest and rowdiest ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
First human trial of AstraZeneca COVID-19 vaccine shows promiseAstraZeneca's experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Japan's Shionogi targets annual vaccine output of 30 millionJapanese drugmaker Shionogi & Co aims to boost production capacity for its potential coronavirus vaccine to produce enough for 30 million people ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Oxford-Astra Covid vaccine shows dual immune action: ResearcherLONDON (BLOOMBERG) - A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Russia says hoping to produce 200 million vaccine doses this yearMOSCOW (AFP) - Russia hopes to complete trials of a coronavirus vaccine in August and produce 200 million doses with foreign partners by the end of the year, the head of its sovereign wealth fund said Monday (July 20).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »